Non-Current Assets
Goodwill
Vertex Pharmaceuticals Goodwill remained flat by 0.0% to $1.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.09B to $1.09B. Over 5 years (FY 2020 to FY 2025), Goodwill shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
A significant increase indicates recent M&A activity, while a decrease suggests potential impairment charges due to underperforming acquisitions.
Detailed definition
This represents the premium paid over the fair market value of identifiable net assets during a business acquisition. It...
Peer comparison
Common in the biotech industry where companies frequently acquire smaller firms to bolster their R&D pipelines.
Metric ID:
goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00B | $1.00B | $1.00B | $1.00B | $1.00B | $1.08B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +7.3% | +1.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +7.3% | +8.6% | +8.6% | +8.6% | +1.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$1.00B – $1.09B
CAGR+1.7%
Avg YoY Growth+2.1%
Median YoY Growth+0.0%
Current Streak19+ quarters growth
Goodwill at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's goodwill?
- Vertex Pharmaceuticals (VRTX) reported goodwill of $1.09B in Q1 2026.
- How has Vertex Pharmaceuticals's goodwill changed year-over-year?
- Vertex Pharmaceuticals's goodwill decreased by 0.0% year-over-year, from $1.09B to $1.09B.
- What is the long-term trend for Vertex Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's goodwill has grown at a 1.7% compound annual growth rate (CAGR), from $1.00B to $1.09B.
- What does goodwill mean?
- The excess cost paid for an acquisition over the fair value of its net assets.